U.S. flag

An official website of the United States government

NM_000260.4(MYO7A):c.1970G>A (p.Arg657Gln) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jan 29, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001856501.4

Allele description [Variation Report for NM_000260.4(MYO7A):c.1970G>A (p.Arg657Gln)]

NM_000260.4(MYO7A):c.1970G>A (p.Arg657Gln)

Gene:
MYO7A:myosin VIIA [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q13.5
Genomic location:
Preferred name:
NM_000260.4(MYO7A):c.1970G>A (p.Arg657Gln)
HGVS:
  • NC_000011.10:g.77174790G>A
  • NG_009086.2:g.51545G>A
  • NM_000260.4:c.1970G>AMANE SELECT
  • NM_001127180.2:c.1970G>A
  • NM_001369365.1:c.1937G>A
  • NP_000251.3:p.Arg657Gln
  • NP_001120652.1:p.Arg657Gln
  • NP_001356294.1:p.Arg646Gln
  • LRG_1420t1:c.1970G>A
  • LRG_1420:g.51545G>A
  • LRG_1420p1:p.Arg657Gln
  • NC_000011.9:g.76885836G>A
  • NC_000011.9:g.76885836G>A
  • NG_009086.1:g.51527G>A
  • NM_000260.3:c.1970G>A
Protein change:
R646Q
Links:
dbSNP: rs375457812
NCBI 1000 Genomes Browser:
rs375457812
Molecular consequence:
  • NM_000260.4:c.1970G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127180.2:c.1970G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369365.1:c.1937G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002111318Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Jan 29, 2024)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Novel myosin mutations for hereditary hearing loss revealed by targeted genomic capture and massively parallel sequencing.

Brownstein Z, Abu-Rayyan A, Karfunkel-Doron D, Sirigu S, Davidov B, Shohat M, Frydman M, Houdusse A, Kanaan M, Avraham KB.

Eur J Hum Genet. 2014 Jun;22(6):768-75. doi: 10.1038/ejhg.2013.232. Epub 2013 Oct 9.

PubMed [citation]
PMID:
24105371
PMCID:
PMC4023209

Phenotype of Usher syndrome type II assosiated with compound missense mutations of c.721 C>T and c.1969 C>T in MYO7A in a Chinese Usher syndrome family.

Zhai W, Jin X, Gong Y, Qu LH, Zhao C, Li ZH.

Int J Ophthalmol. 2015;8(4):670-4. doi: 10.3980/j.issn.2222-3959.2015.04.05.

PubMed [citation]
PMID:
26309859
PMCID:
PMC4539639
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002111318.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 657 of the MYO7A protein (p.Arg657Gln). This variant is present in population databases (rs375457812, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with MYO7A-related conditions. ClinVar contains an entry for this variant (Variation ID: 883481). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MYO7A protein function. This variant disrupts the p.Arg657 amino acid residue in MYO7A. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 24105371, 26309859, 26338283, 27460420). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024